Tamtam Try Tamtam free
Shiseido logo

Shiseido account plan

Cosmetics and beauty products

At a glance

Shiseido is a Tokyo-listed prestige beauty group with FY2025 net sales of ¥970.0 bn and approx. 26,000 employees, now raising its 2026 profit forecast.

Shiseido Company, Limited (TSE: 4911) is a prestige beauty group founded in 1872 in Ginza, Tokyo. Its Core brands are SHISEIDO, Clé de Peau Beauté and NARS, and its Next brands include ELIXIR, ANESSA, fragrances and Dr. Dennis Gross Skincare. In FY2025 (year ended Dec. 31, 2025) it reported net sales of ¥970.0 bn, core operating profit of ¥44.5 bn and a net loss of ¥40.7 bn after a ¥46.8 bn goodwill impairment on the Americas Business. It had approx. 26,000 employees and is an independent, listed company led by CEO Kentaro Fujiwara.

Business units

Strategic priorities

2030 financial targets
Net sales CAGR of 2-5% (like-for-like, 2025-2030 average), a core operating profit margin of 10% or more, ROIC of 10% or more, ROE of 12% or more and free cash flow of ¥100.0 bn or more.
Accelerate growth with brand power
Concentrate on skincare and suncare, then makeup, fragrance, medical & derma and lifestyle. More than ten technologies are to be rolled out across brands by 2028, and Max Mara fragrance is planned for the second half of 2026.
Evolve global operations
Global optimization of the value chain, shorter lead times, brand and SKU reduction, and AI in formulation development and supply planning. A January 2026 reorganization added reporting lines from regional brand heads to global brand leadership.
Dynamic resource allocation
The CEO says budgets will be reallocated dynamically instead of fixed at the start of the year, with brands, regions and corporate functions sharing KPIs for sales, profit and brand value. A second product model aims to cut development time to about half, with launches from the first half of 2027.
ROIC-driven financial discipline
An Investment and Divestment Committee screens brand, IT and capex decisions, and ROIC is built into executive pay. Cash allocation for 2026-2030 targets capex of approx. ¥200.0 bn and dividends of approx. ¥130.0 bn.

Latest results

For the nine months to Sept. 30, 2026, net sales were ¥741,143 million (+6.8% YoY; like-for-like +0.7%) and core operating profit ¥67,458 million, up from ¥30,080 million. China & Travel Retail sales were ¥268,483 million and Japan ¥217,365 million. The company raised its FY2026 forecast to net sales of ¥1,025,000 million and core operating profit of ¥87,000 million (from ¥69,000 million), citing tariff refunds, the weaker yen and company-wide cost management. Like-for-like sales are expected to fall short of the previous forecast, with weak trends in Japan, EMEA, Americas and Asia Pacific.

Investments and deals

Action Plan 2025-2026 cost programme
Expected cost reductions of over ¥72.0 billion for 2024-2026, with ¥27.0 bn of savings in 2025 and more than ¥25.0 bn expected in 2026.
Dr. Dennis Gross Skincare
Acquired in 2024; cash outflows were ¥48.9 bn in 2024 and approx. ¥17.0 bn in 2026.
Capex and IT
Capex is 4.6% of sales in 2025, approx. 4% in 2026 and approx. 3% by 2030, as the FOCUS ERP rollout closes a cycle of major IT investment.
People development
Talent development investment is to rise to approximately three times the 2025 level over five years.
Medical & derma and Beauty Checkup
Expansion into medical & derma through physician collaboration in Japan and co-creation with aesthetic medicine institutions in China, plus Beauty Checkup services after Shiseido Beauty Park opened in January 2025.

Challenges and risks

Sales growth lags profit
The CEO says net sales growth is not satisfactory, and nine-month like-for-like growth was +0.7% against core operating profit of ¥67,458 million.
Americas turnaround
The Americas Business recorded a core operating loss of ¥11.6 bn in 2025 and a ¥46.8 bn goodwill impairment, and Drunk Elephant remains a drag.
China and travel retail softness
Consumer purchases in China were below the prior year in Q3 2026, ANESSA inventory is being optimized and Hong Kong is stagnating.
High fixed costs
The SG&A ratio remains above 70% even after Action Plan 2025-2026, and Japan has a high reliance on inbound sales.
Supply and cyber risks
The board cites procurement risk for petroleum-derived materials from Middle East tension, single-source materials and AI-leveraged cyberattacks.

What leadership says

“While our progress of profit generation has exceeded expectation, net sales growth is not satisfactory.”

Kentaro Fujiwara, President and CEO · Q3 2026 Financial Results Briefing, November 10, 2026

“A drastic strategic review is not necessary, but rather, the operation to execute the strategy has to be changed”

Kentaro Fujiwara, President and CEO · Q3 2026 Financial Results Briefing, November 10, 2026

“This is the final year of the Action Plan, and this is the first year of the midterm management strategy and a turning point for transformation.”

Yoshihiko Hatanaka, External Director and Chair of the Board · Dialogue Between Shiseido's External Directors and Investors, September 16, 2026

Where a supplier can help

Supporting the second product model
The plan to cut development time to about half and launch from the first half of 2027 suggests demand for formulation, packaging and supply partners that shorten lead times.
Value-chain and AI tooling
Pillar 2 targets lead-time reduction, SKU optimization and AI in supply planning and formulation, a fit for supply-chain planning, demand forecasting and data tools, especially where the FOCUS ERP is not yet deployed at some affiliates.
Americas and EMEA go-to-market
With the Americas turnaround, a Drunk Elephant reset and the Max Mara fragrance launch, suppliers of retail and e-commerce growth, marketing-return measurement and retailer data can tie into stated priorities.
ROIC and cost optimization
Cost savings of more than ¥25.0 bn in 2026 and the ROIC-based investment committee point to buyers of procurement, indirect spend and productivity solutions that show a clear return.
AI visibility and customer experience
The board is checking whether Shiseido's data is searchable and recommended by AI, which creates room for AI search visibility and CRM personalization services.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Shiseido?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Shiseido

What does Shiseido do?

Shiseido is a Tokyo-listed prestige beauty group founded in 1872. Its Core brands are SHISEIDO, Clé de Peau Beauté and NARS, and it also owns ELIXIR, ANESSA, fragrance brands and Dr. Dennis Gross Skincare.

How much revenue does Shiseido make?

FY2025 net sales were ¥970.0 bn with core operating profit of ¥44.5 bn. For the nine months to Sept. 30, 2026, net sales were ¥741,143 million, and the FY2026 forecast is ¥1,025,000 million.

How many employees does Shiseido have?

The 2025 integrated report lists approx. 26,000 employees.

What is Shiseido's strategy to 2030?

The 2030 Medium-Term Strategy targets a net sales CAGR of 2-5%, a core operating profit margin of 10% or more, ROIC of 10% or more, ROE of 12% or more and free cash flow of ¥100.0 bn or more, built on three pillars: brand power, global operations and sustainable value creation.

Who leads Shiseido?

Kentaro Fujiwara is Director, Representative Corporate Executive Officer, President and CEO since January 2025, and Ayako Hirofuji is Chief Financial Officer. Yoshihiko Hatanaka, an independent external director, chairs the Board.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)